Opus Genetics outlines five gene therapy programs for retinal diseases
Go back to Opus Genetics outlines five gene therapy programs for retinal diseases| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 5.28 -0.13 (2.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.41 | 52 Week High | $0.02 | |||
| Open | $5.46 | 52 Week Low | $0.02 | |||
| Day High | $5.62 | P/E | N/A | |||
| Day Low | $5.23 | EPS | $0.00 | |||
| Volume | 1,531,534 | |||||
